Laurion Capital Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-5,900
Closed -$301K 1382
2017
Q4
$301K Buy
+5,900
New +$307K ﹤0.01% 1324
2017
Q3
Sell
-5,800
Closed -$295K 1607
2017
Q2
$295K Buy
+5,800
New +$287K ﹤0.01% 1430

Other funds holding CNMD

Laurion Capital Management's CNMD Position: Q1 2018 in Review

Laurion Capital Management sold out of CONMED (CNMD) in Q1 2018, closing a stake of 5,900 shares — an estimated $301K sold.

Laurion Capital Management first reported a position in CNMD in Q2 2017 and held it in 2 quarters. The position peaked at $301K in Q4 2017. 173 funds tracked by Wall St. Rank hold CNMD as of Q1 2018.

  • Laurion Capital Management reported no remaining CONMED position as of Q1 2018 after selling out during the quarter.
  • Laurion Capital Management sold 5,900 CONMED shares in Q1 2018, an estimated $301K.
  • Laurion Capital Management first reported a position in CONMED in Q2 2017 and held it in 2 quarters.
  • Laurion Capital Management's CONMED position peaked at $301K in Q4 2017.
  • 173 funds tracked by Wall St. Rank held CONMED as of Q1 2018.

Based on Laurion Capital Management's 13F filing for Q1 2018, filed 14 May 2018.